Fermata Advisors, LLC Neuronetics, Inc. Transaction History
Fermata Advisors, LLC
- $335 Million
- Q2 2025
A detailed history of Fermata Advisors, LLC transactions in Neuronetics, Inc. stock. As of the latest transaction made, Fermata Advisors, LLC holds 14,765 shares of STIM stock, worth $57,583. This represents 0.02% of its overall portfolio holdings.
Number of Shares
14,765Holding current value
$57,583% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding STIM
# of Institutions
108Shares Held
19.4MCall Options Held
96.2KPut Options Held
58.4K-
Vanguard Group Inc Valley Forge, PA2.31MShares$8.99 Million0.0% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.74MShares$6.78 Million1.44% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.42MShares$5.53 Million0.01% of portfolio
-
Ikarian Capital, LLC Dallas, TX1.1MShares$4.29 Million0.57% of portfolio
-
Masters Capital Management LLC Atlanta, GA1MShares$3.9 Million0.19% of portfolio
About Neuronetics, Inc.
- Ticker STIM
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 27,022,800
- Market Cap $105M
- Description
- Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...